Zika Virus Testing Market

Zika Virus Testing Market by Test Types (Serological Testing, Nucleic Acid Amplification Testing) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1313
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 214
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global zika virus testing market size is projected to register a substantial CAGR during the forecast period attributed to rising participation and involvement from national governments of low-income region and global organizations including UNICEF for public awareness of the disease.

Zika virus, as a disease, is primarily spread by mosquito bites. The disease is mainly caused by the bite of yellow fever mosquitoes, also widely known as Aedes mosquitoes, which is mostly happened during the daytime. As per the study of World Health Organization (WHO), the virus was first identified to be prevailed in monkeys in 1947, later it was discovered in humans in 1952 in Uganda. At present, the virus is active across 86 countries and territories and it is widely known that the virus does not show any severe symptoms. However, some common symptoms including fever, headache, muscle pain, and rash are considered to be associated with the disease. A person who is infected with the virus during pregnancy has higher chance of birth defects including preterm birth, fetal loss, and stillbirth as pregnancy complications. The expected time span to exposure of zika virus symptoms is three to 14 days and they usually last for two to seven days.

Zika Virus Testing

The health authorities in Brazil found a correlation between the virus and neurological birth defects. The highest number of microcephaly cases was recorded between 2015 and 2016 and as a result, a threat to public health was declared in October 2016 in the country. After the end of the zika epidemic in 2016, several research were conducted to develop diagnostics to identify correlation between microcephaly in newborns and the virus. A report by the US Centers for Disease Control and Prevention (CDC) stated that around 5,264 people were infected with the virus in the US, among which 1,700 were pregnant women and 58 babies were born having birth defects. One of the reasons for the virus infection as the epidemic was due to rising number of the virus transmission during travel from one country to other. Around 4,830 cases were registered as travel-related transmission cases in the US in 2016, which was approximately 94.0% of the total cases registered.

Market Trends, Drivers, Restraints, and Opportunities

  • Advancement of technologies in diagnostic tests and increase in RD by pharmaceutical companies are prominent factors driving the market growth.
  • Development of point of care diagnostic kits that can provide quick and accurate results, easy to use, and are cost-effective are expected to push the market growth significantly.
  • Active participation from global major organizations such as UNICEF, WHO, and others along with their wide focus on preventive measures for economic and social impact of the virus outbreak worldwide present a major driver for market growth.
  • Incorporation of blood screening as an addition for zika virus diagnosis in order to prevent transmission is another key driver of the market.
  • Lack of healthcare infrastructure and absence of concrete framework for the virus treatment pose major challenges that can hinder the market expansion.

Scope of the Report

The report on the global zika virus testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes Details
Report Title Zika Virus Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2028
Segmentation Test Types (Serological Testing and Nucleic Acid Amplification Testing)
Regional Scope Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report Roche; Quest Diagnostics, Inc.; Hologic, Inc.; Chembio Diagnostic Systems, Inc.; SD Biosensors, Inc.; Biocan Diagnostics; and Chembio Diagnostics, Inc.

Market Segment Insights

Serological testing segment is projected to constitute a major share

On the basis of test types, the market is bifurcated into serological testing and nucleic acid amplification testing. Both of the serological testing and nucleic acid amplification testing held approximately equal market share in 2020 as these testing are widely used and commercially successful to perform tests to detect the virus. However, the nucleic acid amplification testing segment is expected to hold a key market share in the coming years owing to be cost-effective, easily available, and can be used for mass surveillance.

On the other hand, the serological testing is expected to constitute a major share during the forecast period as they are preferred over nucleic acid amplification testing owing to provide rapid results and can acutely detect the last stage of the virus development.

Zika Virus Testing

North America is anticipated to expand at a considerable CAGR

In terms of regions, the global zika virus testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to expand at a considerable CAGR during the projected period owing to strict regulations for the adoption of the virus testing from regulatory bodies as well as extensive conduct of research activities for the development of better diagnostic and treatment equipment. During the outbreak of the epidemic in 2016, various regulatory frameworks were strictly implemented by collaborating with various global organizations including PAHO, WHO, and CDC to prevent the widespread of the virus especially in the US. It was declared mandatory for North American citizens to undergo nucleic acid amplification testing by donating blood. This factor plays a crucial role that push the growth of the regional market at a large extent.

On the other hand, the market of Latin America is anticipated to register a health growth rate during the forecast period owing to wide prevalence of the disease in many countries of the region and several governments’ initiatives for implementing preventive measures. In 2016, the region had recorded the second highest number of the disease cases, representing more than 50% of the global figure. During the time period of four months from October 2015 to January 2016, more than 4,000 cases were registered with microphelacy in newborns in Brazil; as a result, Brazil’s National Development Bank (BNDES) announced a funding of USD 136.6 million in March 2016 to fight various the illness associated with the virus. This was a leading factor that helped to boost the growth of the regional market.

Zika Virus Testing

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zika Virus Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Zika Virus Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Zika Virus Testing Market - Supply Chain
  4.5. Global Zika Virus Testing Market Forecast
     4.5.1. Zika Virus Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Zika Virus Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Zika Virus Testing Market Absolute $ Opportunity
5. Global Zika Virus Testing Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Zika Virus Testing Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Zika Virus Testing Demand Share Forecast, 2019-2026
6. North America Zika Virus Testing Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Zika Virus Testing Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Zika Virus Testing Demand Share Forecast, 2019-2026
7. Latin America Zika Virus Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Zika Virus Testing Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Zika Virus Testing Demand Share Forecast, 2019-2026
8. Europe Zika Virus Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Zika Virus Testing Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Zika Virus Testing Demand Share Forecast, 2019-2026
9. Asia Pacific Zika Virus Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Zika Virus Testing Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Zika Virus Testing Demand Share Forecast, 2019-2026
10. Middle East & Africa Zika Virus Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Zika Virus Testing Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Zika Virus Testing Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Zika Virus Testing Market: Market Share Analysis
  11.2. Zika Virus Testing Distributors and Customers
  11.3. Zika Virus Testing Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Roche Quest Diagnostics, Inc. Hologic, Inc. Chembio Diagnostic Systems, Inc. SD Biosensors, Inc. Biocan Diagnostics Chembio Diagnostics, Inc.

Segments Covered in the Report

The global zika virus testing market has been segmented on the basis of

Test Types

  • Serological Testing
  • Nucleic Acid Amplification Testing

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Roche
  • Quest Diagnostics, Inc.
  • Hologic, Inc.
  • Chembio Diagnostic Systems, Inc.
  • SD Biosensors, Inc.
  • Biocan Diagnostics
  • Chembio Diagnostics, Inc.

Key players competing in the global zika virus testing market include Roche; Quest Diagnostics, Inc.; Hologic, Inc.; Chembio Diagnostic Systems, Inc.; SD Biosensors, Inc.; Biocan Diagnostics; and Chembio Diagnostics, Inc. Many of these players have adopted business strategies such as improvement in diagnostic products and products approved from the US FDA-EUA to increase their market position and expand their consumer base globally.

Zika Virus Testing

Buy Report